IP Library Granted Patent US 7,704,542
Granted Patent B2
US 7,704,542 · App. 10/242,651 · Granted Apr 27, 2010

Vitamin/mineral compositions with DHA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,704,542
App. No.
10/242,651
Granted
Apr 27, 2010
Kind
B2
Abstract

Compositions containing the fatty acid docosahexaenoic acid (DHA) in combination with at least one vitamin and mineral are provided to supplement nutrition in a mammalian diet. DHA is present in the composition in concentrated amounts, advantageously in a carrier such as marinol oil, to allow for quantities of DHA sufficient to supply expectant and new mothers and their children as recommended on a daily basis. This DHA may also be used to treat a variety of disorders in children and adults. The compositions advantageously include vitamins, minerals, and optionally other nutrients to provide a nutritional supplement which may be convenient to swallow and taken once a day.

Claims (18)

1. A dietary supplement for supplementing the diet of a woman, consisting of:

marinol oil consisting essentially of docosahexaenoic acid (DHA) or pharmaceutically acceptable salt thereof, the DHA present in an amount from about 100 mg to about 600 mg and in a concentration of about 40% to about 60% by weight of the marinol oil,

about 0.002 mg to about 15 mg Vitamin A,

about 2 mcg to about 300 mg Vitamin B,

about 10 mg to about 1000 mg Vitamin C,

about 0.001 mg to about 0.6 mg Vitamin D,

about 1.25 mg to about 125 mg Vitamin E,

about 1 mg to about 100 mg niacinamide,

about 0.1 mg to about 5 mg folic acid,

about 20 mg to about 1000 mg calcium,

about 5 mg to about 100 mg zinc,

about 10 mg to about 200 mg iron in a form selected from the combination of ferrous fumarate and iron-amino acid chelate,

about 0.1 mg to about 10 mg copper, and

about 5 mg to about 400 mg magnesium,

whereby the dietary supplement provides nutrients on a daily basis to women of childbearing age, and during prenatal pregnancy, pregnancy, and postnatal pregnancy.

2. The supplement of claim 1 wherein the DHA is present in a range of from about 180 mg to about 500 mg.

3. The supplement of claim 1 wherein the Vitamin B is selected from the group consisting of Vitamins B 1 , B 2 , B 6 , B 12 , and combinations thereof.

4. The supplement of claim 1 wherein iron is present in an amount of about 10 mg to about 32 mg.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 24, 2011
From: SILVER POINT FINANCE, LLC
To: XANDODYNE PHARMACEUTICALS, INC.
Reel/Frame 027108/0381 →
SECURITY AGREEMENT Recorded Aug 2, 2005
From: XANODYNE PHARMACEUTICALS, INC.
To: SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 016334/0332 →
RELEASE Recorded Jul 20, 2005
From: SILICON VALLEY BANK
To: INTEGRITY PHARMACEUTICAL CORP
Reel/Frame 016791/0316 →
MERGER Recorded Jun 23, 2004
From: INTEGRITY PHARMACEUTICAL CORPORATION
To: XANODYNE PHARMACEUTICALS, INC.
Reel/Frame 014769/0118 →